Determinants of the complement-fixing ability of recipient presensitization against HLA antigens

Transplantation

Volumn 83, Issue 6, 2007, Pages 727-733

  Bartel, Gregor ^a   Wahrmann, Markus ^a   Exner, Markus ^a   Regele, Heinz ^a   Schillinger, Martin ^a   Hörl, Walter H ^a   Böhmig, Georg A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alloantibody; Complement; Immunoglobulin subclass; Panel reactive antibody; Transplantation

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M;

ADULT; ALLOIMMUNITY; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SCREENING; TRANSFUSION;

ADULT; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION TESTS; COMPLEMENT SYSTEM PROTEINS; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34147181150     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000256337.18347.aa     Document Type: Article

References (24)

1. Baldwin WM, Ota H, Rodriguez ER. Complement in transplant rejection: diagnostic and mechanistic considerations. Springer Semin Immunopathol 2003; 25: 181.
2. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665.
3. Feucht HE, Mihatsch MJ. Diagnostic value of C4d in renal biopsies. Curr Opin Nephrol Hypertens 2005; 14: 592.
4. Böhmig GA, Exner M, Habicht A, et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091.
5. Lorenz M, Regele H, Schillinger M, et al. Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort. Transplantation 2004; 78: 447.
6. Cecka JM, Zhang Q, Reed EF. Preformed cytotoxic antibodies in potential allograft recipients: recent data. Hum Immunol 2005; 66: 343.
7. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 1570.
8. Wahrmann M, Exner M, Regele H, et al. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 2003; 275: 149.
9. Wahrmann M, Exner M, Haidbauer B, et al. [C4d]FlowPRA screening - a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Hum Immunol 2005; 66: 526.
10. Wahrmann M, Exner M, Schillinger M, et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006; 6: 1033.
11. Sanfilippo F, Vaughn WK, Bollinger RR, et al. Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation 1982; 34: 360.
12. Burlingham WJ, Stratta R, Mason B, et al. Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience. Transplantation 1989; 47: 140.
13. Rebibou JM, Chabod J, Alcalay D, et al. Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation. Transplantation 2002; 74: 537.
14. Kushihata F, Watanabe J, Mulder A, et al. Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004; 78: 995.
15. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998; 59: 313.
16. Khan N, Robson AJ, Worthington JE, et al. The detection and definition of IgM alloantibodies in the presence of IgM autoantibodies using flowPRA beads. Hum Immunol 2003; 64: 593.
17. Bindon CI, Hale G, Bruggemann M, et al. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med 1988; 168: 127.
18. Griffiths EJ, Nelson RE, Dupont PJ, et al. Skewing of pretransplant anti-HLA class I antibodies of immunoglobulin G isotype solely toward immunoglobulin G1 subclass is associated with poorer renal allograft survival. Transplantation 2004; 77: 1771.
19. Regan J, Monteiro F, Speiser D, et al. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies. Am J Kidney Dis 1996; 28: 92.
20. Le Bas-Bernardet S, Hourmant M, Valentin N, et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003; 75: 477.
21. Worthington JE, Thomas AA, Dyer PA, et al. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome. Transplantation 1998; 65: 121.
22. Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003; 75: 43.
23. Wilson R, Maclean MA, Jenkins C, et al. Abnormal immunoglobulin subclass patterns in women with a history of recurrent miscarriage. Fertil Steril 2001; 76: 915.
24. Gutierrez G, Gentile T, Miranda S, et al. Asymmetric antibodies: a protective arm in pregnancy. Chem Immunol Allergy 2005; 89: 158.